Saisei Mirai Clinics

Saisei Mirai is a prominent Japanese medical group specializing in integrative oncology and regenerative medicine. The organization is globally recognized for its development and clinical application of GcMAF (Macrophage Activating Factor) and personalized cancer immunotherapies. Their treatment protocols often integrate dendritic cell vaccines and natural killer (NK) cell therapies with conventional medical practices. Beyond oncology, the clinics address chronic viral infections and autoimmune conditions using advanced biological therapies. Saisei Mirai operates multiple facilities in Japan, including specialized cell processing centers that adhere to local regenerative medicine regulations. The group also engages in international collaborations to expand the reach of their immunotherapy research and clinical protocols.